Catalog Number 999890143 |
Device Problem
Malposition of Device (2616)
|
Patient Problems
Host-Tissue Reaction (1297); Foreign Body Reaction (1868); Pain (1994); No Information (3190)
|
Event Date 04/23/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.No 510(k) number provided because this implant is sold internationally with different indications for use; it is currently sold in the us under a different part number.The correction/removal reporting number listed applies to the corresponding product code sold domestically.The asr platform was voluntarily recalled from the market in (b)(6) 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken, as there is an ongoing investigation regarding the root cause(s) and/or corrective actions.Ref.Wwcapa (b)(4).Depuy considers the investigation closed at this time.Should the product and/or additional information be received, the investigation will be re-opened.(b)(4).
|
|
Event Description
|
Asr revision.Asr xl- left.Reason(s) for revision: component malalignment.
|
|
Manufacturer Narrative
|
Depuy still considers this investigation closed.
|
|
Event Description
|
(b)(6) 2015 - update - rcvd scf and updated claimsuite - reason for revision is pain not malalignment - (b)(6) 2015 - email rcvd to conf that additional info states metallosis.(b)(6).
|
|
Manufacturer Narrative
|
Asr revision.Asr xl- left.Reason(s) for revision: component malalignment (b)(4) 2015 - update - rcvd scf and updated claimsuite - reason for revision is pain not malalignment - kf (b)(4) 2015.(b)(4) 2015 - email rcvd to conf that additional info states metalosis +++ - kf (b)(4) 2015.The reported event has been evaluated and will be monitored.Depuy considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).Investigation summary: the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa-001226.Ongoing post market surveillance is conducted per our procedures for this product.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|